PL1934252T3 - Sposób wytwarzania koniugatów insuliny - Google Patents
Sposób wytwarzania koniugatów insulinyInfo
- Publication number
- PL1934252T3 PL1934252T3 PL05813799T PL05813799T PL1934252T3 PL 1934252 T3 PL1934252 T3 PL 1934252T3 PL 05813799 T PL05813799 T PL 05813799T PL 05813799 T PL05813799 T PL 05813799T PL 1934252 T3 PL1934252 T3 PL 1934252T3
- Authority
- PL
- Poland
- Prior art keywords
- preparation
- insulin conjugates
- conjugates
- insulin
- Prior art date
Links
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 title 2
- 102000004877 Insulin Human genes 0.000 title 1
- 108090001061 Insulin Proteins 0.000 title 1
- 229940125396 insulin Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/62—Insulins
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Endocrinology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Diabetes (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/IN2005/000338 WO2007043059A1 (en) | 2005-10-13 | 2005-10-13 | Process for the preparation of insulin conjugates. |
| EP05813799.3A EP1934252B1 (en) | 2005-10-13 | 2005-10-13 | Process for the preparation of insulin conjugates. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1934252T3 true PL1934252T3 (pl) | 2015-10-30 |
Family
ID=37942365
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05813799T PL1934252T3 (pl) | 2005-10-13 | 2005-10-13 | Sposób wytwarzania koniugatów insuliny |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8058391B2 (pl) |
| EP (1) | EP1934252B1 (pl) |
| JP (1) | JP5047978B2 (pl) |
| KR (1) | KR101269540B1 (pl) |
| CN (1) | CN101291952B (pl) |
| BR (1) | BRPI0520622B8 (pl) |
| DK (1) | DK1934252T3 (pl) |
| ES (1) | ES2546016T3 (pl) |
| IL (1) | IL190666A (pl) |
| MX (1) | MX2008004674A (pl) |
| PL (1) | PL1934252T3 (pl) |
| PT (1) | PT1934252E (pl) |
| WO (1) | WO2007043059A1 (pl) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11361853B2 (en) | 2002-10-29 | 2022-06-14 | Practice Velocity, LLC | Method and system for automated medical records processing with telemedicine |
| US8168181B2 (en) | 2006-02-13 | 2012-05-01 | Alethia Biotherapeutics, Inc. | Methods of impairing osteoclast differentiation using antibodies that bind siglec-15 |
| DK1994155T4 (da) | 2006-02-13 | 2022-07-25 | Daiichi Sankyo Co Ltd | Polynukleotid- og polypeptidsekvenser involveret i fremgangsmåden med knogleremodellering |
| WO2008049711A1 (en) | 2006-10-27 | 2008-05-02 | Novo Nordisk A/S | Peptide extended insulins |
| WO2009104199A1 (en) * | 2008-02-19 | 2009-08-27 | Biocon Limited | A method of obtaining purified heterologous insulins expressed in yeast |
| KR20110059602A (ko) * | 2008-08-07 | 2011-06-02 | 바이오콘 리미티드 | 인슐린 화합물의 제조방법 |
| US20120123089A1 (en) * | 2009-07-09 | 2012-05-17 | Biocon Limited | Preparative non-linear gradient based chromatographic method and purified products thereof |
| UY33326A (es) | 2010-04-14 | 2011-12-01 | Sanofi Aventis | Conjugados de insulina-sirna |
| US9457096B2 (en) | 2012-07-06 | 2016-10-04 | Consejo Nacional De Investigaciones Cientificas Y Tecnicas (Concet) | Protozoan variant-specific surface proteins (VSP) as carriers for oral drug delivery |
| US9493562B2 (en) | 2012-07-19 | 2016-11-15 | Alethia Biotherapeutics Inc. | Anti-Siglec-15 antibodies |
| SE539197C2 (en) * | 2015-09-15 | 2017-05-09 | Nida Tech Sweden Ab | Positioning system and device comprising an electronic ink display |
| AU2017208935A1 (en) * | 2016-01-23 | 2018-08-30 | Biocon Limited | Bio-analytical method for insulin analogues |
Family Cites Families (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4179337A (en) * | 1973-07-20 | 1979-12-18 | Davis Frank F | Non-immunogenic polypeptides |
| GB2051574B (en) * | 1979-05-10 | 1984-01-18 | Kyoto Pharma Ind | Adjuvant for promoting absorption of pharmacologically active substances through the rectum |
| IL68769A (en) * | 1983-05-23 | 1986-02-28 | Hadassah Med Org | Pharmaceutical compositions containing insulin for oral administration |
| US5182258A (en) * | 1989-03-20 | 1993-01-26 | Orbon Corporation | Systemic delivery of polypeptides through the eye |
| US5321095A (en) * | 1993-02-02 | 1994-06-14 | Enzon, Inc. | Azlactone activated polyalkylene oxides |
| US5359030A (en) * | 1993-05-10 | 1994-10-25 | Protein Delivery, Inc. | Conjugation-stabilized polypeptide compositions, therapeutic delivery and diagnostic formulations comprising same, and method of making and using the same |
| TW402506B (en) * | 1993-06-24 | 2000-08-21 | Astra Ab | Therapeutic preparation for inhalation |
| GB9417524D0 (en) * | 1994-08-31 | 1994-10-19 | Cortecs Ltd | Pharmaceutical compositions |
| GB9516268D0 (en) * | 1995-08-08 | 1995-10-11 | Danbiosyst Uk | Compositiion for enhanced uptake of polar drugs from the colon |
| US6011008A (en) * | 1997-01-08 | 2000-01-04 | Yissum Research Developement Company Of The Hebrew University Of Jerusalem | Conjugates of biologically active substances |
| IT1291623B1 (it) * | 1997-04-18 | 1999-01-11 | Bracco Spa | Procedimento per la coniugazione di chelanti con molecole contenenti gruppi amminici |
| JP3406244B2 (ja) * | 1999-04-30 | 2003-05-12 | 伊藤ハム株式会社 | 新規な融合蛋白質からの組み換えインスリンの製造方法 |
| US6309633B1 (en) * | 1999-06-19 | 2001-10-30 | Nobex Corporation | Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same |
| US6828297B2 (en) * | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
| WO2003022996A2 (en) * | 2001-09-07 | 2003-03-20 | Nobex Corporation | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| US6770625B2 (en) * | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
| US7312192B2 (en) | 2001-09-07 | 2007-12-25 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
| WO2004044206A1 (en) * | 2002-11-12 | 2004-05-27 | Ckd Bio Corp. | Plasmids expressing human insulin and the preparation method for human insuling thereby |
| KR101152470B1 (ko) | 2003-08-13 | 2012-06-01 | 바이오콘 리미티드 | 치료제용 마이크로-입자 지방산 염 고형 투약 제형 |
| KR101225679B1 (ko) * | 2005-07-08 | 2013-01-23 | 바이오콘 리미티드 | 인슐린 복합체의 제조 |
-
2005
- 2005-10-13 JP JP2008535192A patent/JP5047978B2/ja not_active Expired - Fee Related
- 2005-10-13 WO PCT/IN2005/000338 patent/WO2007043059A1/en not_active Ceased
- 2005-10-13 CN CN200580051831.0A patent/CN101291952B/zh not_active Expired - Fee Related
- 2005-10-13 BR BRPI0520622A patent/BRPI0520622B8/pt not_active IP Right Cessation
- 2005-10-13 ES ES05813799.3T patent/ES2546016T3/es not_active Expired - Lifetime
- 2005-10-13 EP EP05813799.3A patent/EP1934252B1/en not_active Expired - Lifetime
- 2005-10-13 MX MX2008004674A patent/MX2008004674A/es active IP Right Grant
- 2005-10-13 US US12/083,275 patent/US8058391B2/en active Active
- 2005-10-13 PT PT58137993T patent/PT1934252E/pt unknown
- 2005-10-13 KR KR1020087009648A patent/KR101269540B1/ko not_active Expired - Fee Related
- 2005-10-13 PL PL05813799T patent/PL1934252T3/pl unknown
- 2005-10-13 DK DK05813799.3T patent/DK1934252T3/en active
-
2008
- 2008-04-07 IL IL190666A patent/IL190666A/en active IP Right Grant
Also Published As
| Publication number | Publication date |
|---|---|
| EP1934252A4 (en) | 2010-07-14 |
| IL190666A (en) | 2014-08-31 |
| PT1934252E (pt) | 2015-10-12 |
| BRPI0520622A2 (pt) | 2009-05-19 |
| KR20080067625A (ko) | 2008-07-21 |
| IL190666A0 (en) | 2008-11-03 |
| US20110020871A1 (en) | 2011-01-27 |
| CN101291952B (zh) | 2016-02-03 |
| JP2009511039A (ja) | 2009-03-19 |
| WO2007043059A1 (en) | 2007-04-19 |
| MX2008004674A (es) | 2008-11-12 |
| BRPI0520622B1 (pt) | 2021-04-13 |
| US8058391B2 (en) | 2011-11-15 |
| JP5047978B2 (ja) | 2012-10-10 |
| EP1934252A1 (en) | 2008-06-25 |
| BRPI0520622B8 (pt) | 2021-05-25 |
| DK1934252T3 (en) | 2015-08-31 |
| KR101269540B1 (ko) | 2013-05-30 |
| ES2546016T3 (es) | 2015-09-17 |
| CN101291952A (zh) | 2008-10-22 |
| EP1934252B1 (en) | 2015-06-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3872058T3 (en) | Process for the preparation of 2,3,3,3 tetrahydrofluoropropene | |
| IL190666A0 (en) | Process for the preparation of insulin conjugates | |
| IL248076B (en) | A process for preparing purified drug compounds | |
| PL1993985T3 (pl) | Sposób wytwarzania 1,2-propanodiolu | |
| EP1881847B8 (de) | Optimierte injektionsformulierung für mrna | |
| PL1912671T3 (pl) | Koniugaty beta-glukuronid-linker-lek | |
| IL185917A0 (en) | Immunogenic molecules | |
| IL188330A0 (en) | Processes for the preparation of | |
| IL188431A0 (en) | Process for preparing 3-arylmethylthio-and 3-heteroarylmethylthio-4,5-dihydro- | |
| PL1926386T3 (pl) | Ulepszony sposób wytwarzania herbaty | |
| ZA200804264B (en) | Process for the preparation of ferri-succinylcasein | |
| EP1879634A4 (en) | IMPROVED SYRINGE | |
| ZA200904270B (en) | Novel bis(dialkylamide) compounds, process for the preparation thereof and uses thereof | |
| AP2374A (en) | Isoxazoline derivative and novel process for its preparation. | |
| EP1922345A4 (en) | PROCESS FOR THE PREPARATION OF COPOLYMER-1 | |
| ZA200608083B (en) | Process for preparing 5-methyl-2-furfural | |
| TWI372145B (en) | Process for preparing alkylanilides | |
| IL190325A (en) | A process for making loopfin | |
| ZA200601910B (en) | Process for the preparation of organosilances | |
| EP1996192A4 (en) | PROCESS FOR PREPARING 3,4-SUBSTITUTED THIAZOLIDIN-2-ONES IN 3,4 | |
| EG25401A (en) | Process for the preparation of urea. | |
| IL187658A0 (en) | Process for the preparation of 3,7-dihydroxy-1,5-diazacyclooctanes | |
| IL187673A0 (en) | Process for preparing 3,3-diarylpropylamines | |
| TWI365869B (en) | Process for the preparation of phenol | |
| PL1857120T3 (pl) | Infuzje do leczenia zapalenia gruczołów mlekowych |